Manager, Trial Supply Management at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, Clinical TrialsIndustries

Requirements

Ability to create and maintain supply strategies for investigational product based on scientific and regulatory confines with minimal supervision
Capability to work independently while mentoring others and acting as a consultant to teams outside the role
Robust knowledge and confidence of Global Clinical Supply Chain (GCSC) processes for presenting at cross-functional meetings

Responsibilities

Collaborates with internal GCSC teams and external customers/service providers (e.g., Global Drug Development, Pharmaceutical Development, PDQ, External Vendors, Medical) to ensure all needs are met
Proactively defines, plans, and communicates clinical supply chain strategy for global clinical studies to ensure optimal use and alignment with study/corporate goals
Generates and drives strategies for continuous improvement at departmental and inter-departmental levels
Influences clinical and development timelines, study design, and country selection; reviews and provides input to draft clinical protocols; communicates timelines and investigational product strategies to teams
Develops supply forecasts for complex studies via clinical development plan and protocol analysis; monitors inventory and analyzes drug utilization vs. forecast, considering country requirements and logistical timelines
Issues Manufacturing and Packaging/Labeling requests to Clinical Supply Operations (CSO) aligned with RDSC Master Planning timelines, collaborating with Clinical Development, CMC, and CSO teams to meet protocol/regulatory requirements
Monitors use date of investigational drug product; supports use date extension activities (e.g., UDE memo generation) and provides feedback to Logistics for UDE labels
Ensures timely delivery of quality clinical supplies for assigned compounds/protocols, collaborating internally/externally while accounting for country Regulatory and QP Release requirements
Participates in development, review, and approval of Interactive Response Technology (IRT) specifications; develops investigational product distribution strategies and maintains them at depot/site level per study/IRT requirements
Actively participates in internal meetings (e.g., Trial Supply Management, Clinical Supply Chain, Study Team, Clinical Supply Matrix Team), providing relevant data/documentation, highlighting risks and mitigation strategies

Skills

Supply Chain Management

Clinical Supply Strategy

Global Clinical Supply Chain

Cross-Functional Collaboration

Supply Planning

Mentoring

GCSC Processes

Pharmaceutical Development

Regulatory Compliance

Continuous Improvement

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free